The specificity of BAF47 in cell proliferation control is probably the reason why this tumor suppressor is inactivated in almost all the rhabdomyosarcomas, while the BRG1 inactivation is less frequent. This evidence concerns the gene SMARCB1 and rhabdomyosarcoma.